All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0041 | Anti-RLBP1 (B2) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | B2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0941 | Anti-RLBP1 (B2) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | B2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3215 | Anti-RLBP1 (CBFYC-3080) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBFYC-3080 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3216 | Anti-RLBP1 (CBFYC-3081) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-3081 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6468 | Anti-RLBP1 (CBFYC-3080) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBFYC-3080 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6469 | Anti-RLBP1 (CBFYC-3081) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-3081 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2024 | Anti-RLBP1 (B2) h(41BB-CD3ζ) CAR, pCDCAR1 | B2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ2025 | Anti-RLBP1 (CBWJC-4378) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJC-4378 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ2026 | Anti-RLBP1 (CBWJC-4379) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJC-4379 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4316 | Anti-RLBP1 (B2) h(CD28-CD3ζ) CAR, pCDCAR1 | B2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4317 | Anti-RLBP1 (CBWJC-4378) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJC-4378 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4318 | Anti-RLBP1 (CBWJC-4379) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJC-4379 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION